The outcome in myasthenia gravis patients – an eight-year follow-up after finishing immunoabsorption therapy

J.M. Schneidewind(PHV Dialysezentrum), R. Benecke(Children's Hospital of Philadelphia), Heinrich Prophet(PHV Dialysezentrum), Uwe K. Zettl(University of Rostock), Annika E. Michelsen(PHV Dialysezentrum), Michael Tiess(PHV Dialysezentrum), Warren E. Patow(PHV Dialysezentrum), G Hebestreit(PHV Dialysezentrum), Roland Winkler(Leibniz Institute for Astrophysics Potsdam), Wolfgang Ramlow(Rostocker Zentrum zur Erforschung des Demografischen Wandels)
Transfusion and Apheresis Science
February 1, 2001
10.1016/s0955-3886(00)00125-9
Cited by 2

Related Papers

Transcranial magnetic stimulation of the human brain: responses in muscles supplied by cranial nerves
|Experimental Brain Research|1988|304
On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects
|Experimental Brain Research|1993|303
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke
|Stroke|2000|298
Reorganisation of descending motor pathways in patients after hemispherectomy and severe hemispheric lesions demonstrated by magnetic brain stimulation
|Experimental Brain Research|1991|292
Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency
|Journal of Neurology|1999|276